The 57 rating InvestorsObserver gives to Dare Bioscience Inc (DARE) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 82 percent of stocks in the Biotechnology industry, DARE’s 57 overall rating means the stock scores better than 57 percent of all stocks.
Click Here to get the full Stock Score Report on Dare Bioscience Inc (DARE) Stock.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Dare Bioscience Inc Stock Today?
Dare Bioscience Inc (DARE) stock has fallen -2% while the S&P 500 is up 0.47% as of 11:00 AM on Tuesday, Nov 12. DARE has fallen -$0.02 from the previous closing price of $0.90 on volume of 492,526 shares. Over the past year the S&P 500 is higher by 13.76% while DARE has fallen -3.30%. DARE lost -$1.56 per share the over the last 12 months.
